| Medical and Health Sciences | Lifetime | 532 | US 287 | 99.98 |
| Mathematics and Statistics | Lifetime | 604 | US 264 | 99.06 |
| Medical and Health Sciences | 2021-2025 | 284 | US 101 | 99.94 |
| Mathematics and Statistics | 2021-2025 | 143 | US 17 | 98.90 |
| Statistics, Probability and Uncertainty | Lifetime | 37 | US 11 | 99.64 |
| General Health Professions | Lifetime | 503 | US 261 | 99.43 |
| Public, Environmental and Occupational Health | Lifetime | 461 | US 229 | 99.35 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 300 | US 167 | 99.10 |
| Pulmonary and Respiratory Medicine | Lifetime | 902 | US 466 | 98.53 |
| Internal Medicine | Lifetime | 394 | US 160 | 90.18 |
| Hepatology | Lifetime | 782 | US 290 | 84.85 |
| Gastroenterology | Lifetime | 663 | US 247 | 78.22 |
| Statistics, Probability and Uncertainty | 2021-2025 | 29 | US 4 | 99.08 |
| Surgery | 2021-2025 | 357 | US 141 | 97.41 |
| General Health Professions | 2021-2025 | 639 | US 226 | 94.95 |
| Public, Environmental and Occupational Health | 2021-2025 | 568 | US 214 | 94.55 |
| Econometrics and Quantitative Economics | 2021-2025 | 755 | US 205 | 95.29 |
| Epidemiology | 2021-2025 | 696 | US 245 | 93.28 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 290 | US 119 | 93.24 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 553 | US 239 | 91.64 |
| Oncology | 2021-2025 | 704 | US 311 | 89.01 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 851 | US 311 | 88.70 |
| Genetics | 2021-2025 | 685 | US 259 | 79.24 |
| Clinical practice guidelines implementation | Lifetime | 6 | US 1 | 99.89 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 58 | US 27 | 99.76 |
| Meta-analysis and systematic reviews | Lifetime | 12 | US 2 | 99.70 |
| Health Sciences Research and Education | Lifetime | 27 | US 7 | 99.15 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 388 | US 162 | 98.89 |
| Health Policy Implementation Science | Lifetime | 120 | US 55 | 98.46 |
| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 753 | US 374 | 98.52 |
| COVID-19 and healthcare impacts | Lifetime | 326 | US 125 | 95.75 |
| Healthcare cost, quality, practices | Lifetime | 204 | US 115 | 97.15 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 964 | US 408 | 97.74 |
| Diabetes Treatment and Management | Lifetime | 719 | US 265 | 97.49 |
| Pituitary Gland Disorders and Treatments | Lifetime | 551 | US 199 | 97.25 |
| Adrenal and Paraganglionic Tumors | Lifetime | 390 | US 141 | 96.63 |
| Peripheral Artery Disease Management | Lifetime | 877 | US 461 | 95.80 |
| Statistical Methods in Clinical Trials | Lifetime | 425 | US 222 | 95.25 |
| Vascular Procedures and Complications | Lifetime | 912 | US 485 | 95.04 |
| Pharmacology and Obesity Treatment | Lifetime | 561 | US 238 | 94.34 |
| Adrenal Hormones and Disorders | Lifetime | 891 | US 322 | 92.49 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | Lifetime | 816 | US 353 | 92.00 |
| Delphi Technique in Research | Lifetime | 729 | US 123 | 88.05 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 760 | US 186 | 87.43 |
| Male Breast Health Studies | Lifetime | 173 | US 70 | 84.07 |
| Reliability and Agreement in Measurement | Lifetime | 229 | US 92 | 82.79 |
| Academic Writing and Publishing | Lifetime | 752 | US 304 | 47.35 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 47 | US 14 | 99.12 |
| Clinical practice guidelines implementation | 2021-2025 | 10 | US 2 | 98.31 |
| Meta-analysis and systematic reviews | 2021-2025 | 14 | US 2 | 99.06 |
| Cardiac, Anesthesia and Surgical Outcomes | 2021-2025 | 651 | US 231 | 94.73 |
| COVID-19 and healthcare impacts | 2021-2025 | 703 | US 240 | 91.08 |
| Healthcare cost, quality, practices | 2021-2025 | 161 | US 75 | 90.52 |
| Statistical Methods in Clinical Trials | 2021-2025 | 140 | US 57 | 90.59 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 872 | US 294 | 91.87 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 988 | US 310 | 87.74 |
| Reliability and Agreement in Measurement | 2021-2025 | 14 | US 3 | 84.21 |
| Peripheral Artery Disease Management | 2021-2025 | 724 | US 306 | 86.11 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 744 | US 440 | 83.93 |
| Health Sciences Research and Education | 2021-2025 | 166 | US 61 | 80.25 |
| Adrenal Hormones and Disorders | 2021-2025 | 333 | US 49 | 82.00 |
| Adrenal and Paraganglionic Tumors | 2021-2025 | 760 | US 132 | 78.86 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | 2021-2025 | 416 | US 165 | 75.52 |
| Delphi Technique in Research | 2021-2025 | 611 | US 66 | 72.70 |
| Body Contouring and Surgery | 2021-2025 | 683 | US 250 | 69.58 |
| Social Media in Health Education | 2021-2025 | 607 | US 265 | 67.96 |